Kodiak Sciences Inc (KOD)
2.365
-0.16
(-6.52%)
USD |
NASDAQ |
Jun 26, 12:45
Kodiak Sciences Shareholders Equity (Quarterly): 241.19M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 241.19M |
| December 31, 2023 | 265.78M |
| September 30, 2023 | 302.42M |
| June 30, 2023 | 338.48M |
| March 31, 2023 | 392.59M |
| December 31, 2022 | 436.17M |
| September 30, 2022 | 479.53M |
| June 30, 2022 | 530.93M |
| March 31, 2022 | 597.38M |
| December 31, 2021 | 663.32M |
| September 30, 2021 | 726.32M |
| June 30, 2021 | 779.43M |
| March 31, 2021 | 821.68M |
| Date | Value |
|---|---|
| December 31, 2020 | 860.75M |
| September 30, 2020 | 281.78M |
| June 30, 2020 | 309.20M |
| March 31, 2020 | 327.69M |
| December 31, 2019 | 345.36M |
| September 30, 2019 | 59.69M |
| June 30, 2019 | 70.02M |
| March 31, 2019 | 80.10M |
| December 31, 2018 | 86.83M |
| September 30, 2018 | -93.83M |
| June 30, 2018 | 16.66M |
| December 31, 2017 | -68.74M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
59.69M
Minimum
Sep 2019
860.75M
Maximum
Dec 2020
441.48M
Average
368.97M
Median
Shareholders Equity (Quarterly) Benchmarks
| Avalo Therapeutics Inc | -101.08M |
| Regeneron Pharmaceuticals Inc | 26.99B |
| Ligand Pharmaceuticals Inc | 806.52M |
| iBio Inc | 24.86M |
| Dare Bioscience Inc | -11.00M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 434.76M |
| Total Liabilities (Quarterly) | 193.57M |